Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Temperature excursions

The product was stored or shipped outside its labeled temperature range. Heat or freezing can degrade a drug without any visible change, so it may be weaker than labeled.

569 FDA drug recalls with this cause, newest first.

Vaccines, insulin, many injectables and some tablets must stay within a narrow temperature band from factory to pharmacy. A truck without working refrigeration, a freezer failure or a warehouse heatwave is enough: the product looks normal but may have lost potency or formed degradation products. FDA files these under 'CGMP deviations' or 'temperature abuse'; we track them separately because the question to ask - how was my medication stored? - is different from every other cause.

Class II · Moderate risk

Colgate Total SF Toothpaste

CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Terminated Temperature excursion Cardinal Healthcare D-0174-2024
Class II · Moderate risk

CITALOPRAM Tablets

CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Terminated Temperature excursion Cardinal Healthcare D-0173-2024
Class II · Moderate risk

CHLORTHALIDONE Tablets

CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Terminated Temperature excursion Cardinal Healthcare D-0172-2024
Class II · Moderate risk

Bumetanide Tablets

CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Terminated Temperature excursion Cardinal Healthcare D-0171-2024
Class II · Moderate risk

Low Dose ASPIRIN

CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Terminated Temperature excursion Cardinal Healthcare D-0170-2024
Class II · Moderate risk

Asmanex Twisthaler

CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Terminated Temperature excursion Cardinal Healthcare D-0169-2024
Class II · Moderate risk

Armour Thyroid

CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Terminated Temperature excursion Cardinal Healthcare D-0168-2024
Class II · Moderate risk

Aripiprazole Tablets

CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Terminated Temperature excursion Cardinal Healthcare D-0167-2024
Class II · Moderate risk

AMOXICILLIN Tablets

CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Terminated Temperature excursion Cardinal Healthcare D-0166-2024
Class II · Moderate risk

ALLOPURINOL Tablets

CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Terminated Temperature excursion Cardinal Healthcare D-0164-2024
Class II · Moderate risk

Sodium Chloride 0.9%

Temperature Abuse: Product exposed to temperature outside specified limits.

Terminated Temperature excursion Fresenius Medical Care Holdings, Inc. NDC 46163-0300-10 D-0603-2021
Class I · High risk

Xultophy 100/3.6

Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.

Terminated Temperature excursion Novo Nordisk Inc NDC 0169-2911-90 D-0623-2021